Skip to main content

Table 3 Treatment of sinus aspergilloma and impact on TNFα antagonist therapy

From: Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

Case

Systemic antifungal treatment

Surgical treatment

Impact on TNFα antagonist therapy

1

--

Aspergilloma removal after meatotomy in January 2005

Temporary discontinuation

2

--

May 2007

Treatment stopped before surgery

3

--

August 2005, September 2006

Temporary discontinuation

4

--

Aspergilloma removal by endoscopy in June 2007

Treatment stopped before surgery

5

--

Aspergilloma removal after meatotomy in January 2005

TNFα antagonist therapy considered contraindicated because of the aspergilloma

6

--

Aspergilloma removal after meatotomy in August 2006, December 2006, September 2007

TNFα antagonist therapy delayed for 18 months